Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aerie Pharmaceuticals Inc (NASDAQ:AERI)

64.05
Delayed Data
As of Oct 16
 +2.60 / +4.23%
Today’s Change
32.05
Today|||52-Week Range
66.10
+69.22%
Year-to-Date

Today’s Trading

Previous close61.45
Today’s open61.70
Day’s range61.65 - 64.60
Volume764,319
Average volume (3 months)603,145
Market cap$2.2B
Dividend yield--
Data as of 10/16/2017

Growth & Valuation

Earnings growth (last year)-18.06%
Earnings growth (this year)+4.37%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book19.52

Competitors

 Today’s
change
Today’s
% change
AXONAxovant Sciences Ltd-0.01-0.16%
ENDPEndo International P...-0.55-6.73%
HZNPHorizon Pharma PLC-0.32-2.30%
CORTCorcept Therapeutics...+0.95+5.30%
Data as of 10/16/2017

Financials

Next reporting dateDecember 6, 2017
EPS forecast (this quarter)-$0.66
Annual revenue (last year)$0.00
Annual profit (last year)-$99.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Vicente J. Anido
President &
Chief Operating Officer
Thomas A. Mitro
Corporate headquarters
Irvine, California

Forecasts